BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 28722140)

  • 1. Erythrocyte-Membrane-Enveloped Perfluorocarbon as Nanoscale Artificial Red Blood Cells to Relieve Tumor Hypoxia and Enhance Cancer Radiotherapy.
    Gao M; Liang C; Song X; Chen Q; Jin Q; Wang C; Liu Z
    Adv Mater; 2017 Sep; 29(35):. PubMed ID: 28722140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy.
    Ren H; Liu J; Li Y; Wang H; Ge S; Yuan A; Hu Y; Wu J
    Acta Biomater; 2017 Sep; 59():269-282. PubMed ID: 28663143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles.
    Zhou Z; Zhang B; Wang H; Yuan A; Hu Y; Wu J
    Theranostics; 2018; 8(18):4898-4911. PubMed ID: 30429876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorinated Hyaluronic Acid Encapsulated Perfluorocarbon Nanoparticles as Tumor-Targeted Oxygen Carriers to Enhance Radiotherapy.
    Wang W; Wang X; Tao F; Hu K; Zhang J; Wu J; You L; Zhao W
    Mol Pharm; 2022 Nov; 19(11):3948-3958. PubMed ID: 36194775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TaOx decorated perfluorocarbon nanodroplets as oxygen reservoirs to overcome tumor hypoxia and enhance cancer radiotherapy.
    Song G; Ji C; Liang C; Song X; Yi X; Dong Z; Yang K; Liu Z
    Biomaterials; 2017 Jan; 112():257-263. PubMed ID: 27768978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A co-delivery nanoplatform for a lignan-derived compound and perfluorocarbon tuning IL-25 secretion and the oxygen level in tumor microenvironments for meliorative tumor radiotherapy.
    Duan Z; Luo Q; Gu L; Li X; Zhu H; Gu Z; Gong Q; Zhang H; Luo K
    Nanoscale; 2021 Aug; 13(32):13681-13692. PubMed ID: 34477643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application.
    Xia Q; Zhang Y; Li Z; Hou X; Feng N
    Acta Pharm Sin B; 2019 Jul; 9(4):675-689. PubMed ID: 31384529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluorocarbon-Encapsulated PLGA-PEG Emulsions as Enhancement Agents for Highly Efficient Reoxygenation to Cell and Organism.
    Yao Y; Zhang M; Liu T; Zhou J; Gao Y; Wen Z; Guan J; Zhu J; Lin Z; He D
    ACS Appl Mater Interfaces; 2015 Aug; 7(33):18369-78. PubMed ID: 26222132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment.
    Zhang Z; Qian H; Yang M; Li R; Hu J; Li L; Yu L; Liu B; Qian X
    Int J Nanomedicine; 2017; 12():1593-1605. PubMed ID: 28280328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Starvation-amplified CO generation for enhanced cancer therapy via an erythrocyte membrane-biomimetic gas nanofactory.
    Wang Y; Liu Z; Wang H; Meng Z; Wang Y; Miao W; Li X; Ren H
    Acta Biomater; 2019 Jul; 92():241-253. PubMed ID: 31078766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies.
    Song X; Feng L; Liang C; Yang K; Liu Z
    Nano Lett; 2016 Oct; 16(10):6145-6153. PubMed ID: 27622835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen tank for synergistic hypoxia relief to enhance mitochondria-targeted photodynamic therapy.
    Li X; Wang H; Li Z; Li D; Lu X; Ai S; Dong Y; Liu S; Wu J; Guan W
    Biomater Res; 2022 Sep; 26(1):47. PubMed ID: 36138489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte Membrane-Wrapped pH Sensitive Polymeric Nanoparticles for Non-Small Cell Lung Cancer Therapy.
    Gao L; Wang H; Nan L; Peng T; Sun L; Zhou J; Xiao Y; Wang J; Sun J; Lu W; Zhang L; Yan Z; Yu L; Wang Y
    Bioconjug Chem; 2017 Oct; 28(10):2591-2598. PubMed ID: 28872851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Perfluorocarbon-Based Delivery Systems for Cancer Theranostics.
    Yang Y; Liu Y; Jiang Y
    Mol Pharm; 2023 Jul; 20(7):3254-3277. PubMed ID: 37318162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.
    Guo Y; Wang D; Song Q; Wu T; Zhuang X; Bao Y; Kong M; Qi Y; Tan S; Zhang Z
    ACS Nano; 2015 Jul; 9(7):6918-33. PubMed ID: 26153897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte-Membrane-Coated Prussian Blue/Manganese Dioxide Nanoparticles as H
    Peng J; Yang Q; Li W; Tan L; Xiao Y; Chen L; Hao Y; Qian Z
    ACS Appl Mater Interfaces; 2017 Dec; 9(51):44410-44422. PubMed ID: 29210279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration.
    Miyazawa T; Nakagawa K; Harigae T; Onuma R; Kimura F; Fujii T; Miyazawa T
    Int J Nanomedicine; 2015; 10():7223-30. PubMed ID: 26664113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cell delivery and cell membrane camouflaged PLGA nanoparticles in the delivery of shikonin for colorectal cancer treatment.
    Zhou J; Jiang Z; Sun R; Pan D; Du Q; Zhou X; Chen Y; Chen Y; Peng J
    Colloids Surf B Biointerfaces; 2024 Jun; 241():114017. PubMed ID: 38865869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygenated theranostic nanoplatforms with intracellular agglomeration behavior for improving the treatment efficacy of hypoxic tumors.
    Zhou J; Xue C; Hou Y; Li M; Hu Y; Chen Q; Li Y; Li K; Song G; Cai K; Luo Z
    Biomaterials; 2019 Mar; 197():129-145. PubMed ID: 30641264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinspired nanocarriers for an effective chemotherapy of hepatocellular carcinoma.
    Xu L; Wu S; Zhou X
    J Biomater Appl; 2018 Jul; 33(1):72-81. PubMed ID: 29699442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.